Ignite Creation Date:
2024-05-06 @ 3:23 PM
Last Modification Date:
2024-10-26 @ 1:48 PM
Study NCT ID:
NCT04610528
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-06-23
First Post:
2020-10-27
Brief Title:
A Window-of-opportunity Study of U3-1402 a HER3-targeting Antibody-drug Conjugate in Operable Breast Cancer According to ERBB3 Expression
Sponsor:
SOLTI Breast Cancer Research Group
Organization:
SOLTI Breast Cancer Research Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-22
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-10-27
First Submit QC Date:
October 29 2020
Study First Post Date:
2020-10-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-21
Last Update Post Date:
2023-06-23
Last Update Post Date Type:
ACTUAL